Skip to content

Socket Preservation Using Autogenous Bone Graft Versus MPM

Dental Implant Placement in Extraction Socket of Mandibular Anterior and Premolar Areas Treated With Mineralized Plasmatic Matrix Versus Autogenous Bone Graft

Status
UNKNOWN
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03008538
Enrollment
20
Registered
2017-01-02
Start date
2016-09-30
Completion date
2017-12-31
Last updated
2017-01-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Graft; Complications

Brief summary

Studying the comparative effectiveness of socket preservation using autogenous bone graft versus MPM for implant insertion.

Detailed description

To assess bone quality, stability of implants placed in fresh extraction sockets of mandibular anterior and premorals augmented by MPM (Mineralized Plasmatic Matrix) versus autogenous bone graft (gold standard), at different follow-up periods (0, 3, 6, 9 months).

Interventions

OTHERMPM(Mineralized plasmatic matrix).

Preparation of sticky bone graft by addition of growth factors obtained from patient's vebous blood.

Socket preservation using autogenous bone graft for preservation of bone width and height for future implant insertion.

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

1. Medically free patients. 2. Patients with mandibular anterior and premolar hopeless teeth indicated for extraction. 3. Evaluated bone height on X.Ray to be (0-4 mm buccal bone dehiscence). 4. Age between 18 and 40 years. 5. Both sexes. 6. Patients physically able to tolerate surgical and restorative procedures. Good oral hygiene. 7. Highly motivated patients.

Exclusion criteria

1. Smokers. 2. Pregnant or lactating females. 3. Presence of any pathosis in the pre-implant site. 4. Presence of Para functional habits. 5. History of oral radiotherapy. 6. History of prolonged steroids use 7. Psychological disorders.

Design outcomes

Primary

MeasureTime frame
Patient Satisfaction regarding function, to be measured using patient questionnaire.3 Months.

Secondary

MeasureTime frame
Comparative histomorphometric analysis, to be measured using a digital software called (leica QWin 500) and unit of measurements are to be (Pixels).3 Months.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026